&w=3840&q=100)
Delhi govt orders CCTV cameras in chemist shops to curb misuse of medicines
The order mainly focuses on high-risk medicines like codeine-based cough syrups, alprazolam tablets, and tramadol capsules. These are drugs that can be misused for intoxication and are often consumed by minors without proper medical supervision.
NCORD meeting sparks action against misuse
This move follows a meeting held under the 11th National Narcotics Coordination Portal (NCORD). The main goal of the meeting was to find ways to stop the sale of prescription drugs listed under Schedule H, H1, and X without a doctor's advice.
Authorities acted after getting complaints that these drugs were being misused not only by people but also in other industries like textiles, chemicals, and food. The Delhi government, along with the Narcotics Control Bureau (NCB), hopes that setting up CCTV cameras will help in tracking and reducing illegal drug sales, the news report said.
On this decision, an official letter said: "As per provisions of the National Narcotics Coordination Portal, in collaboration with the Narcotics Control Bureau, has been advised to stop, prevent and discourage the sale of dual-use medicines without prescription and an advisory dated August 1, 2024 on this matter was already issued earlier." i
Understanding Schedule H, H1, and X drugs
*Schedule H drugs include commonly used medicines like painkillers and flu drugs. Though they need a prescription, they are often sold over the counter without one.
*Schedule H1 drugs come under stricter rules. Chemists are required to maintain a record of these sales, including the doctor's and patient's details.
*Schedule X drugs are under the highest level of regulation. These include psychotropic substances, which have a high risk of misuse. They can only be sold with a valid prescription, and their storage is closely checked by authorities.
All chemists and medical shops have been asked to install CCTV cameras by the end of this month. The cameras are expected to act as a deterrent to illegal sales and help authorities keep a better watch over medicine distribution.
Hashtags
Try Our AI Features
Explore what Daily8 AI can do for you:
Comments
No comments yet...
Related Articles
Hindustan Times
10 hours ago
- Hindustan Times
Karnataka minister addresses heart attack deaths: ‘No increase, nothing to panic'
"Getting your heart checked once a year is sufficient. There's no need to panic and visit hospitals out of fear," said Sharan Prakash Patil, Karnataka's minister for medical education on Tuesday. The belief that these cases are occurring only in Hassan is incorrect, Patil said.(ANI) 'The average number of heart attack cases is similar to last year,' Patil said, clarifying that there is no need to panic over the reportedly 'increasing' cases of heart attacks. 'The government is taking appropriate measures,' he affirmed. What caused panic in the state? Patil noted that after reports of a surge in heart attack cases in the state's Hassan district, patients have been swarming hospitals like the renowned Sri Jayadeva Institute of Cardiovascular Sciences and Research, in Bengaluru. 'There has been a rise in people seeking preventive checks as well. This has created an unusual situation,' he added. He assured that a study is being conducted on the deaths of 24 individuals in Hassan. Further talking of the deaths in Hassan, he said that based on preliminary findings, among the 24 cases, only 10 were due to heart attacks and that the remaining were due to other causes. Does Covid-19 vaccine trigger heart attacks? Patil clarified that there is no link between the Covid-19 vaccine and the heart attack cases. 'People should not doubt the vaccine. The belief that these cases are occurring only in Hassan is incorrect,' he confirmed. Patil further explained that the lifestyle changes brought by the post Covid scenario have led to a rise in diabetes and blood pressure cases. "Dietary habits have changed, and stress levels have increased. We are studying the reasons behind the rise in deaths among youth," he added. 'Focus on lifestyle' Patil urged people to focus on leading a healthy lifestyle instead of being scared of heart attacks. He stressed on getting adequate sleep, and exercising regularly. 'Only those showing symptoms of heart-related illness should go for a medical check-up. Don't rush to hospitals without a reason,' he advised. Have heart attack cases increased in the state? An expert analysis led by cardiologist KS Ravindranath at Bengaluru's Jayadeva Hospital discovered that the number of deaths from heart attacks has not increased. According to a release by the authorities, in January, 178 people were admitted, with 11 deaths reported. In February, 10 out of 181 patients died, in March, 9 out of 200 died and in Bengaluru, 2,165 were hospitalised, with 101 deaths reported. Do children need screening? Karnataka health minister Dinesh Gundu Rao said that there is no need for screening children for heart diseases. 'We will be organising awareness programmes through Jayadeva Hospital. We are also taking strict action on roadside food vendors and unhygienic food preparation methods,' he said. Reiterating what Patil said about a healthy lifestyle, Rao urged people to stick to traditional dietary practices. He also recommended yoga as a highly beneficial habit.
Mint
20 hours ago
- Mint
NRIs turning to India for high-quality quality affordable healthcare, customers up 150% YoY in FY25: Report
New Delhi [India], July 28 (ANI): Non-Resident Indians (NRIs) are increasingly choosing India as their destination for high-quality and affordable healthcare, according to the data released by Policybazaar. The data showed a significant 150 per cent growth in the share of NRI customers in FY 2024-25 compared to FY 2023-24, highlighting India's growing appeal in the global medical tourism space. It stated, "India is fast emerging as one of the world's most sought-after medical tourism hubs. The growth is quite visible with more NRIs turning to India to access high-quality healthcare. Our data indicates a 150 per cent overall growth in the share of NRI customers in FY 25". One of the key reasons behind this mentioned in the data report is the surge is the massive cost advantage India offers for medical treatments when compared to countries like the United States and the United Kingdom. For instance, heart bypass surgery in India costs between USD 5,000 and USD 8,000, while the same procedure in the U.S. can cost between USD 70,000 and USD 150,000. Similarly, a knee replacement surgery costs only USD 4,000 to USD 6,000 in India, compared to USD 30,000 to USD 50,000 in the U.S. A liver transplant in India is priced between USD 25,000 and USD 35,000, whereas it costs USD 300,000 to USD 500,000 in the U.S. NRIs opting for elective procedures in India typically have average claim amounts ranging from USD 2,000 to USD 15,000. For more complex surgeries, the claims may rise to USD 20,000 to USD 40,000, still representing considerable savings when compared to international healthcare costs. The affordability factor also extends to health insurance premiums. In India, the average annual health insurance premium per person ranges from USD 120 to USD 300. In contrast, the same coverage in the U.S. can exceed USD 8,000 annually, while in GCC countries, it ranges from USD 4,000 to USD 5,000. This significant difference has led to a visible increase in online searches by NRIs exploring health insurance options in India for themselves and their families. The data further reveals a 125 per cent surge in the share of women NRI customers and a 148 per cent increase in the number of NRI customers under the age of 35. This showed that younger NRIs and women are increasingly considering Indian healthcare as a preferred choice. When it comes to preferred locations for treatment, South Indian cities continue to dominate the list across all tiers. Cities like Mumbai, Kolkata, Pune, and Thane are also gaining popularity among NRI patients. With a combination of quality care, advanced medical infrastructure, and substantial cost benefits, India is rapidly emerging as a leading hub for NRI medical needs. (ANI)
Mint
4 days ago
- Mint
CCTVs now mandatory in pharmacies to combat drug abuse by children
New Delhi: Pharmacies and chemist shops across the nation will now be required to install CCTV cameras to strengthen efforts against drug and substance abuse by children. The new mandate is a key part of a joint action plan developed by the National Commission for Protection of Child Rights (NCPCR), the Narcotics Control Bureau (NCB), and the Narco Coordination Centre (NCORD). Their directive urges states and Union Territories to prevent the sale of controlled substances—specifically Schedule H, H1, and X drugs—to minors. Schedule H drugs are those that can be sold only on the prescription of a registered medical practitioner. Schedule H1 includes specific third and fourth-generation antibiotics, some habit-forming drugs, and anti-TB drugs. Schedule X drugs are those with a high potential for abuse or dependence and include amphetamines, barbiturates, and certain narcotics. The new surveillance measure targets commonly misused medications such as codeine-based cough syrups (Schedule H1) and Alprazolam tablets and Tramadol capsules, which are Schedule X drugs. This initiative comes in response to alarming statistics on substance use among minors in India. About 2 million children aged 10-17 were users of sedatives for non-medical purposes, according to the National Survey on Extent and Pattern of Substance Use in India conducted in 2018. The survey indicated that about 4 million children in this age group were opioid users, although a breakdown for pharmaceutical opioids was not available. The 2018 data, released by the ministry of social justice and empowerment through the National Drug Dependence Treatment Centre (AIIMS) remains the latest comprehensive national survey on substance use among Indian children. "It has been advised to stop, prevent and discourage the sale of dual-use medicines without a prescription," an official familiar with the matter said. "During the NCORD meeting, CCTV installation was urged at chemist or pharmacy shops across all states/UTs so that health authorities can verify records." Taking the initiative, the Delhi government's drugs control department issued directives on 22 July to chemist associations within its jurisdiction, asking them not to sell Schedule H, H1, and X drugs to minors without a prescription from a registered medical practitioner. 'Assistant Drugs Controllers/Licensing Authorities and Drugs Inspectors of the Government of NCT of Delhi are now tasked with monitoring and ensuring strict adherence to these new regulations. All Chemist Associations in Delhi have been urged to disseminate this crucial information to their members for immediate compliance,' the Delhi government said. The Retail Distribution Chemist Alliance (RDCA) has circulated the CCTV installation directive to members. However, it has sought clarifications for effective compliance about whether the mandate is a legal requirement under the Drugs and Cosmetics Act or merely an advisory. 'We also need to know if NCB guidelines directly apply to standard retail pharmacies, given their operations fall under the Drugs and Cosmetics Act. Furthermore, we've asked if additional record-keeping or surveillance protocols are now mandatory. To avoid confusion, the RDCA urges a clear, formal directive, preferably under the Drugs Act, if CCTV installation is compulsory,' the alliance leadership said. They emphasized their commitment to ethical practices and public health, seeking clarity for full compliance.
